We are live on ! Find out more
TMCI icon

Treace Medical Concepts

119 hedge funds and large institutions have $260M invested in Treace Medical Concepts in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 35 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more call options, than puts

Call options by funds: $27K | Put options by funds: $3K

23% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 35

15% more capital invested

Capital invested by funds: $226M → $260M (+$34.2M)

0.34% more ownership

Funds ownership: 61.11%61.46% (+0.34%)

5% less funds holding

Funds holding: 125119 (-6)

29% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 21

Holders
119
Holders Change
-6
Holders Change %
-4.8%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
15
Increased
43
Reduced
35
Closed
21
Calls
$27K
Puts
$3K
Net Calls
+$24K
Net Calls Change
+$11K
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Armistice Capital
New York
$42.4M +$366K +56,000 +0.9%
BlackRock
2
BlackRock
New York
$24.7M -$548K -83,998 -2%
William Blair Investment Management
3
William Blair Investment Management
Illinois
$24.4M +$3.49M +534,486 +17%
Vanguard Group
4
Vanguard Group
Pennsylvania
$18.3M +$40.7K +6,240 +0.2%
GS
5
Gagnon Securities
New York
$15.2M +$52.8K +8,090 +0.4%
Millennium Management
6
Millennium Management
New York
$11.5M +$1.26M +192,929 +13%
CIBC Private Wealth Group
7
CIBC Private Wealth Group
Georgia
$11.3M -$6.53K -1,000 -0.1%
JP Morgan Chase
8
JP Morgan Chase
New York
$10.8M -$1.07M -163,680 -9%
First Eagle Investment Management
9
First Eagle Investment Management
New York
$8.31M +$2.16M +330,866 +36%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$7.69M +$175K +26,826 +2%
State Street
11
State Street
Massachusetts
$6.66M +$38.2K +5,855 +0.6%
GA
12
Gagnon Advisors
New York
$6.5M +$902K +138,194 +17%
Deutsche Bank
13
Deutsche Bank
Germany
$6.25M +$41K +6,273 +0.7%
PHP
14
Parkman Healthcare Partners
Connecticut
$5.69M +$24K +3,677 +0.4%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$5.11M -$405K -62,023 -8%
Morgan Stanley
16
Morgan Stanley
New York
$5.1M -$1.69M -259,120 -25%
OM
17
Opaleye Management
Massachusetts
$4.71M +$4.59M +702,245 New
CP
18
CenterBook Partners
Connecticut
$4.53M +$729K +111,660 +20%
Northern Trust
19
Northern Trust
Illinois
$2.9M -$18K -2,753 -0.6%
Charles Schwab
20
Charles Schwab
California
$2.78M +$395K +60,567 +17%
AI
21
Acuitas Investments
Washington
$2.02M +$1.97M +301,100 New
UBS Group
22
UBS Group
Switzerland
$1.9M -$614K -94,098 -25%
Acadian Asset Management
23
Acadian Asset Management
Massachusetts
$1.82M +$850K +130,212 +92%
PCMI
24
Paradigm Capital Management Inc
New York
$1.68M -$119K -18,161 -7%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$1.64M +$149K +22,867 +10%

TMCI Hedge Fund Activity: Q3 2025 in Review

119 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q3 2025, worth a combined $260M — up 15% from $226M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of TMCI and 15 opened new positions — a net loss of 6 holders — while 35 trimmed existing stakes and 43 added.

The largest buyer was Opaleye Management, opening a new position worth an estimated $4.59M. The largest seller was Kornitzer Capital Management, exiting entirely with an estimated $2.15M sold.

  • 119 institutional investors held Treace Medical Concepts (TMCI) as of Q3 2025, down from 125 in Q2 2025.
  • Funds reported $260M of Treace Medical Concepts stock for Q3 2025, up 15% quarter-over-quarter.
  • 15 funds opened new Treace Medical Concepts positions in Q3 2025 and 21 closed out, a net change of -6 holders.
  • The largest Treace Medical Concepts buyer in Q3 2025 was Opaleye Management, an estimated $4.59M added.
  • The largest Treace Medical Concepts seller in Q3 2025 was Kornitzer Capital Management, an estimated $2.15M sold.

Based on aggregated 13F filings for Q3 2025.